Iterum Therapeutics plc Stock Price: Quote, Forecast, Splits & News (ITRM)

ITRM

Iterum Therapeutics plc

Financial information provided by Financial Modeling Prep. Options data provided by Unusual Whales. Live transcripts provided by Quartr. Reported revenue and EPS data from Earnings powered by FinChat.io. All data is provided for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice.

Symbol: ITRM
Market Cap: $37M
IPO Date: May 25, 2018
CEO: Corey N. Fishman
Fulltime Employees: 9
Sector: Healthcare
Industry: Biotechnology
Country: IE
Exchange: NASDAQ Capital Market

Peers

Watchlist

	2021	2022	2023	2024
Market Cap	$961	$10	$26	$35
- Cash	27	21	6	24
+ Debt	25	28	19	46
Enterprise Value	958	18	38	56
Revenue	0	0	0	0
% Growth	-	-	-	-
Gross Profit	-2	-2	-2	-0.3
% Margin	0.0%	0.0%	0.0%	0.0%
EBITDA	-83	-40	-35	-19
% Margin	0.0%	0.0%	0.0%	0.0%
Net Income	-92	-44	-38	-25
% Margin	0.0%	0.0%	0.0%	0.0%
EPS Diluted	-8.41	-3.63	-2.96	-1.26
% Growth	-	-56.8%	-18.5%	-57.4%
Operating Cash Flow	-16	-18	-39	-27
Capital Expenditures	-0.1	-0.1	-0.0	-0.0
Free Cash Flow	-16	-19	-39	-27